Tag Archives: Xenograft Model Antitumor Assays/methods

Vascular disruption in combination with mTOR inhibition in renal cell carcinoma

Ellis L, Shah P, Hammers H, Lehet K, Sotomayor P, Azabdaftari G, Seshadri M, Pili R. Vascular disruption in combination with mTOR inhibition in renal cell carcinoma. Mol Cancer Ther. February 2012;11(2):383-392. Full Text – Open Access Publication Date February 2012 How Analyze was Used “Image processing and analysis were carried out using commercially available…

A human brainstem glioma xenograft model enabled for bioluminescence imaging

Hashizume R, Ozawa T, Dinca EB, Banerjee A, Prados MD, James CD, Gupta N. A human brainstem glioma xenograft model enabled for bioluminescence imaging. J Neurooncol. January 2010;96(2):151-159. Full Text – Open Access Publication Date January 2010 How Analyze was Used “For the volumetric assessment of intracranial tumor, tumor regions were identified on serially-sectioned H&E…

MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas

Seshadri M, Ciesielski MJ. MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas. J Cereb Blood Flow Metab. August 2009;29(8):1373-1382. Full Text – Open Access Publication Date August 2009 How Analyze was Used “After image acquisition, raw image sets were transferred to a processing workstation and converted into Analyze format (AnalyzeDirect, Version 8.0, Overland…

Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models

Desnoyers LR, Pai R, Ferrando RE, Hötzel K, Le T, Ross J, Carano R, D’Souza A, Qing J, Mohtashemi I, Ashkenazi A, French DM. Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene. January 2008;27(1):85-97. Full Text – Open Access Publication Date January 2008 How Analyze was Used…